Clinical validation is essential but expensive. For diagnostic innovators, particularly startups and smaller companies, the cost of clinical trials can be a significant barrier to market entry.
However, cost-effective clinical validation is not about cutting corners. It is about making smart strategic choices.
The global validation landscape
Clinical trial costs vary dramatically by geography. Sites in North America and Western Europe are among the most expensive in the world, while sites in South Asia, Southeast Asia, Latin America, and Africa can offer comparable quality at significantly lower costs.
The key is identifying sites that combine affordability with the clinical expertise, patient populations, and regulatory environment needed for your specific diagnostic technology.
ISO 14155 as a universal standard
ISO 14155 provides an internationally recognized framework for the design, conduct, and reporting of clinical investigations of medical devices, including diagnostics. By designing studies that align with ISO 14155, innovators can generate evidence that is accepted across multiple regulatory jurisdictions.
This standard-based approach eliminates the need for redundant studies in different markets, significantly reducing overall validation costs.
Site selection strategies
Effective site selection goes beyond cost comparison. Key factors include disease prevalence and patient demographics, site experience with similar technologies, institutional review board efficiency, sample handling and storage capabilities, and data management infrastructure.
The best sites combine competitive pricing with deep scientific expertise and efficient operational processes.
Adaptive trial designs
Adaptive trial designs allow studies to be modified based on interim data without undermining statistical validity. This approach can reduce sample sizes, shorten timelines, and lower costs while maintaining the evidentiary quality needed for regulatory submissions.
Decentralized and hybrid approaches
The COVID-19 pandemic accelerated adoption of decentralized clinical trial approaches. For diagnostic validation, hybrid models that combine centralized sample analysis with decentralized patient recruitment can offer significant cost and timeline advantages.
The Dxplora advantage
Dxplora maintains a global network of validated clinical sites optimized for diagnostic studies. We help innovators design cost-effective validation strategies that meet international standards and generate evidence accepted by regulatory authorities worldwide.
Our approach is simple: maximize evidence quality while minimizing unnecessary cost and complexity.